CJC-IPAMORELIN Blend
Dose
Overview
Research Use Only
This product is intended for laboratory research use only. It is not intended for human consumption, therapeutic, or diagnostic use. Handle in accordance with good laboratory practices.
What Is the CJC-Ipamorelin Blend?
History
True Research Certified
Certificate of Analysis
Third-party lab tested. Full purity and endotoxin reports available.
Research Use Only
This product is intended for laboratory research use only. It is not intended for human consumption, therapeutic, or diagnostic use. Handle in accordance with good laboratory practices.
What Is the CJC-Ipamorelin Blend?
The CJC-1295/Ipamorelin blend combines a synthetic GHRH analogue (CJC-1295) with a synthetic pentapeptide (Ipamorelin), both referenced in published preclinical literature. Supplied as a lyophilized peptide blend manufactured to ≥99% purity.
Overview
A research-grade lyophilized blend of CJC-1295 and Ipamorelin peptides, manufactured to ≥99% individual component purity with third-party verification. For research use only.
History
CJC-1295 was developed as a synthetic GHRH analogue with enhanced stability through amino acid substitutions. Ipamorelin was identified through peptide library screening and first described by Raun et al. in 1998. Both compounds have extensive published preclinical research histories.
Research Findings
This peptide blend carries the True Research Certified designation, awarded exclusively to compounds that achieve verified ≥99% purity through independent third-party HPLC and mass spectrometry analysis. True Research Certified products undergo batch-level endotoxin screening via the LAL (Limulus Amebocyte Lysate) method and are accompanied by a comprehensive Certificate of Analysis (COA) documenting purity, identity, and endotoxin results. This certification reflects our commitment to supplying only the highest-grade research materials to the scientific community.